Industry Updates for the Psychedelics World

Psychedelics News

Industry

8 Apr 2025

No More Silence: The Opioid Epidemics Alarming Impact on Women

Women are facing a silent crisis in the opioid epidemic, with overdose deaths among women aged 30–64 skyrocketing by 260% since 1999. Beyond the statistics lie the stories of mothers,...

By Madison Roberts

Industry, Psychedelic Titans, Science

31 Mar 2025

The Future of Psychedelics: Why Next-Generation Molecules Will Win

The psychedelic industry is undergoing a major transformation. With new, non-hallucinogenic compounds on the rise, companies like Enveric Biosciences, Delix Therapeutics, and Gilgamesh Pharmaceuticals are leading the way in developing...

By Madison Roberts

Industry

1 Jan 2025

The Psychedelic Industry in 2025: A New Era of Healing and Transformation

The psychedelic industry is poised for groundbreaking advancements in 2025, from new clinical applications to state-level regulatory frameworks. Experts highlight the potential for treating PTSD, depression, and addiction while addressing...

By Madison Roberts

Industry

3 Dec 2024

Enveric Biosciences Receives Two US Patents for Psilocybin Derivatives

Enveric Biosciences announced two new patents from the USPTO for its EVM301 and EVM201 series, boosting its total patents to 11 for EVM301. These patents safeguard groundbreaking psilocybin derivatives and...

By Madison Roberts

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

16 Nov 2024

atai Life Sciences and Enveric Biosciences Report Q3 2024 Results

In their Q3 2024 financial updates, atai Life Sciences and Enveric Biosciences demonstrate fiscal discipline and innovation. atai maintains funding into 2026 with a promising psychedelic therapy pipeline, while Enveric...

By Madison Roberts

Industry

6 Nov 2024

Enveric Biosciences Expands Patent Portfolio

Enveric Biosciences has expanded its intellectual property portfolio with five new U.S. patents for compounds in its EVM301 portfolio, positioning the company as a leader in innovative treatments for neuropsychiatric...

By Madison Roberts

Industry

6 Nov 2024

One Billion People

Over 100 million people suffer from treatment-resistant depression, a relentless form of depression that current treatments cannot alleviate. Atai Life Sciences is stepping up with innovative solutions like VLS-01, a...

By Madison Roberts

Breaking News, Don’t Miss, Health & Wellness, Industry

4 Nov 2024

SoundSelf’s Wefunder Campaign: Bringing Digital Psychedelics to Mental Health Providers

SoundSelf, the groundbreaking digital therapeutics company, is launching a community investment campaign on Wefunder. This Austin-based innovator aims to revolutionize mental health care by using immersive technology to support mental...

By Madison Roberts

Industry

15 Jul 2024

Integrating SoundSelf in Ketamine Clinics: Enhancing Patient Outcomes Through Immersive Technology

Ketamine clinics are revolutionizing mental health treatment for those with resistant depression and other conditions. Integrating SoundSelf, an immersive biofeedback and neurostimulation technology, can further enhance these therapies. This article...

By Madison Roberts

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result